TAVR in bicuspid aortic valve stenosis: "We are not there yet" to draw final conclusions

TY - JOUR

T1 - TAVR in bicuspid aortic valve stenosis: "We are not there yet" to draw final conclusions

AU - De Backer, Ole

AU - Søndergaard, Lars

N1 - © 2018 Wiley Periodicals, Inc.

PY - 2018/4/1

Y1 - 2018/4/1

N2 - TAVR for bicuspid AS is not associated with excess mortality, but paravalvular leak and pacemaker implant is increased compared to tricuspid AS cohorts undergoing TAVR. Operators should weigh these potential complications against the clinical benefit obtained with TAVR for bicuspid AS patients at high surgical risk. A randomized controlled trial comparing TAVR with SAVR in younger, low-surgical risk patients with-or at least not excluding-bicuspid AS is strongly needed.

AB - TAVR for bicuspid AS is not associated with excess mortality, but paravalvular leak and pacemaker implant is increased compared to tricuspid AS cohorts undergoing TAVR. Operators should weigh these potential complications against the clinical benefit obtained with TAVR for bicuspid AS patients at high surgical risk. A randomized controlled trial comparing TAVR with SAVR in younger, low-surgical risk patients with-or at least not excluding-bicuspid AS is strongly needed.

KW - Aortic Valve/abnormalities

KW - Aortic Valve Stenosis

KW - Bicuspid/surgery

KW - Heart Valve Diseases

KW - Humans

KW - Transcatheter Aortic Valve Replacement

KW - Treatment Outcome

U2 - 10.1002/ccd.27606

DO - 10.1002/ccd.27606

M3 - Editorial

C2 - 29634859

SN - 1522-1946

VL - 91

SP - 984

EP - 985

JO - Catheterization and Cardiovascular Interventions

JF - Catheterization and Cardiovascular Interventions

IS - 5

ER -